Jailendra Singh
Stock Analyst at Truist Securities
(0.99)
# 3,649
Out of 4,761 analysts
171
Total ratings
29.03%
Success rate
-21.95%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMWL American Well | Maintains: Hold | $10 → $12 | $11.74 | +2.21% | 6 | Feb 14, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $284 → $262 | $201.39 | +30.10% | 8 | Feb 13, 2025 | |
| IQV IQVIA Holdings | Reiterates: Buy | $261 → $263 | $191.04 | +37.67% | 14 | Feb 10, 2025 | |
| EVH Evolent Health | Maintains: Buy | $20 → $15 | $10.43 | +43.82% | 4 | Jan 22, 2025 | |
| VEEV Veeva Systems | Maintains: Hold | $261 → $210 | $225.79 | -6.99% | 7 | Jan 13, 2025 | |
| ASTH Astrana Health | Maintains: Buy | $59 → $50 | $35.68 | +40.13% | 4 | Jan 13, 2025 | |
| PHR Phreesia | Maintains: Buy | $31 → $34 | $28.22 | +20.48% | 5 | Dec 11, 2024 | |
| DOCS Doximity | Maintains: Hold | $35 → $49 | $72.37 | -32.29% | 6 | Nov 14, 2024 | |
| PGNY Progyny | Downgrades: Hold | $26 → $19 | $23.20 | -18.10% | 9 | Nov 13, 2024 | |
| PRVA Privia Health Group | Maintains: Buy | $24 → $27 | $24.52 | +10.11% | 6 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $415 → $397 | $340.22 | +16.69% | 2 | Oct 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $7.5 | $6.93 | +8.23% | 15 | Oct 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $15 → $10 | $11.51 | -13.12% | 15 | Aug 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $13 → $23 | $49.28 | -53.33% | 7 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $12.98 | +7.86% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.4 → $6.5 | $3.52 | +84.66% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7.5 → $8 | $4.81 | +66.32% | 11 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $10.05 | +29.35% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $42 → $43 | $6.22 | +591.32% | 6 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $4.92 | +387.80% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $4.57 | -12.47% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $127.06 | -54.35% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $17.94 | +150.84% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $597.71 | -44.29% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $4.40 | +104.55% | 2 | May 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | n/a | $18.61 | - | 3 | Jan 15, 2021 |
American Well
Feb 14, 2025
Maintains: Hold
Price Target: $10 → $12
Current: $11.74
Upside: +2.21%
ICON Public Limited Company
Feb 13, 2025
Maintains: Buy
Price Target: $284 → $262
Current: $201.39
Upside: +30.10%
IQVIA Holdings
Feb 10, 2025
Reiterates: Buy
Price Target: $261 → $263
Current: $191.04
Upside: +37.67%
Evolent Health
Jan 22, 2025
Maintains: Buy
Price Target: $20 → $15
Current: $10.43
Upside: +43.82%
Veeva Systems
Jan 13, 2025
Maintains: Hold
Price Target: $261 → $210
Current: $225.79
Upside: -6.99%
Astrana Health
Jan 13, 2025
Maintains: Buy
Price Target: $59 → $50
Current: $35.68
Upside: +40.13%
Phreesia
Dec 11, 2024
Maintains: Buy
Price Target: $31 → $34
Current: $28.22
Upside: +20.48%
Doximity
Nov 14, 2024
Maintains: Hold
Price Target: $35 → $49
Current: $72.37
Upside: -32.29%
Progyny
Nov 13, 2024
Downgrades: Hold
Price Target: $26 → $19
Current: $23.20
Upside: -18.10%
Privia Health Group
Nov 8, 2024
Maintains: Buy
Price Target: $24 → $27
Current: $24.52
Upside: +10.11%
Oct 14, 2024
Maintains: Hold
Price Target: $415 → $397
Current: $340.22
Upside: +16.69%
Oct 9, 2024
Maintains: Buy
Price Target: $9 → $7.5
Current: $6.93
Upside: +8.23%
Aug 2, 2024
Maintains: Hold
Price Target: $15 → $10
Current: $11.51
Upside: -13.12%
Jul 18, 2024
Maintains: Hold
Price Target: $13 → $23
Current: $49.28
Upside: -53.33%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $12.98
Upside: +7.86%
May 24, 2024
Maintains: Hold
Price Target: $6.4 → $6.5
Current: $3.52
Upside: +84.66%
Mar 1, 2024
Maintains: Hold
Price Target: $7.5 → $8
Current: $4.81
Upside: +66.32%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $10.05
Upside: +29.35%
Feb 28, 2022
Maintains: Neutral
Price Target: $42 → $43
Current: $6.22
Upside: +591.32%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $4.92
Upside: +387.80%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $4.57
Upside: -12.47%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $127.06
Upside: -54.35%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $17.94
Upside: +150.84%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $597.71
Upside: -44.29%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $4.40
Upside: +104.55%
Jan 15, 2021
Downgrades: Underperform
Price Target: n/a
Current: $18.61
Upside: -